missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Lysates
  5. Overexpression Lysates
  6. 18232891

R&D Systems™ Creatine Kinase BB Overexpression Lysate

Product Code. 18232891 Shop All Bio Techne Products
Change view
Click to view available options
Quantity:
0.1 mg
Unit Size:
0.1mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity Unit Size
18232891 0.1 mg 0.1mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 18232891 Supplier R&D Systems™ Supplier No. NBL109218
 Restricted Item
Estimated Shipment: 18-11-2026
Add to basket
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

Description

A Novus product, part of R&D Systems.

The Creatine Kinase BB Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.
TRUSTED_SUSTAINABILITY

Specifications

Cell Line The lysate was created in HEK293T cells, using plasmid ID RC23669 and based on accession number NM_1823. The protein contains a C-terminal DDK tag.
Quantity 0.1 mg
Storage Buffer RIPA buffer
Purity Protein
Test Specificity Homo sapiens creatine kinase, brain (CKB), mRNA.
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Product Line Novus
Research Category Cancer
Target Creatine Kinase BB
Synonym Creatine Kinase Isoenzyme
Gene Symbol CKB
Protein State Native
For Use With (Application) Western Blot
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.